
National Association of Testing Authorities, Australia
Scope of Accreditation
Australian Clinical Labs
Site
Murarrie Laboratory
Accreditation No.
3427
Site No.
25018
Date of Accreditation
23 Nov 2021
Contact
Ms Sam Rowe
P: +61 0439310414
Availability
Services available to external clients
Supervision
B (Branch)
Scope of Accreditation
Withdrawn 27 Feb 2023
Voluntary
Murarrie Laboratory
ISO 15189 (2012)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Anatomical pathology - Tissue pathology - Examination of biopsy material | ||
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Dry swabs; Nasopharyngeal and throat swab | Adenovirus; Enterovirus; Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus type 1/2/3; Respiratory syncytial virus (RSV); Rhinovirus |
Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) - PCR, RT-PCR | |
Nasopharyngeal and throat swab | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
3427
Site No.
25018
Print date
09 Dec 2023
END OF SCOPE